resources

Shukra Pharmaceuticals Ltd.

BSE: 524632

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

31.86-0.5 (-1.42%)

24 Jul, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Shukra Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	—	—	—	—	—	—	—	—	—	—	Jun Sept	Mar
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Shukra Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Outcome without intimation14 Jul 2026
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On Monday, July 14, 2026 For Confirmation Of Receipt Of The Differential Upfront Consideration From The Allottees Pursuant To Regulation 170(2) Of The SEBI (ICDR) Regulations, 2018
The Board took on record and confirmed that, in accordance with the terms of the aforesaid Special Resolution and the applicable provisions of Chapter V of the SEBI ICDR Regulations, the ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Reg 74(5)
EGM6 Jul 2026
EGM Voting Results
EGM Voting Results
EGM6 Jul 2026
Shareholder Meeting / Postal Ballot-Outcome of EGM
EGM
Closure of Trading Window23 Jun 2026
Closure of Trading Window
Closure of Trading Window
Outcome without intimation15 Jun 2026
Board Meeting Outcome for Appointment And Resignation Of Company Secretary & Compliance Officer
Appointment and Resignation of Company Secretary & Compliance Officer
Newspaper Publication13 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication pertaining to EGM to be held on 6th July 2026
EGM12 Jun 2026
Notice Of EGM To Be Held On 6Th July 2026
Notice of EGM to be held on 6th July 2026
Outcome of Board Meeting10 Jun 2026
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Wednesday, June 10, 2026
Outcome of the meeting of the Board of Directors held on Wednesday, June 10, 2026
Board Meeting5 Jun 2026
Board Meeting Intimation for Ratification Of Approval For Member''s Resolution Passed In The Extra-Ordinary General Meeting Dated 01St November, 2025
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2026 ,inter alia, to consider and approve Ratification of Approval ....
Newspaper Publication9 May 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Standalone Audit Financial Results for Fourth Quarter and Financial Year ended on 31st March 2026
Allotment of Equity Shares7 May 2026
Announcement under Regulation 30 (LODR)-Allotment
PREFRENTIAL WARRANTS ALLOTMENT
Reg.24(A)-Annual Secretarial Compliance7 May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Regulation 24A for the period ended march 31, 2026
Dividend7 May 2026
Corporate Action-Board approves Dividend
the board has recommended and declared the dividend of Rs. 0.01/- (1%)
Reg. 32 (1), (3) - Statement of Deviation & Variation7 May 2026
Regulation 32 For Starement Of Deviation
for the quarter and half year ended march, 2026 the statement of deviation under reg 32
Outcome of Board Meeting7 May 2026
Board Meeting Outcome for Outcome For The Board Meeting Dated 07.05.2026 For The Audited Financial Results For The Quarter And Year Ended March, 2026
Audited Financial Results for the wquarter ended march31, 2026, recommendation and declaration of dividend , allotment of prefrential warrants
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A29 Apr 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....
Board Meeting29 Apr 2026
Board Meeting Intimation for Audited Financial Result For The Quarter And Financial Year Ended On 31St March, 2026 Along With The Auditor''s Report
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 ,inter alia, to consider and approve Audited financial result ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Apr 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74(5)
Closure of Trading Window20 Mar 2026
Closure of Trading Window
Closure of Trading Window

Frequently Asked Questions

Where can I download the annual report of Shukra Pharmaceuticals Ltd.?

Annual reports of Shukra Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Shukra Pharmaceuticals Ltd.?

Quarterly earnings results and presentations of Shukra Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Shukra Pharmaceuticals Ltd. publish earnings call transcripts?

Earnings call transcripts of Shukra Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Shukra Pharmaceuticals Ltd.?

Investor presentations and annual day presentations of Shukra Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Shukra Pharmaceuticals Ltd.?

Corporate announcements and regulatory filings of Shukra Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Shukra Pharmaceuticals Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Shukra Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Shukra Pharmaceuticals Ltd.?

The ISIN (International Securities Identification Number) of Shukra Pharmaceuticals Ltd. is INE551C01044. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Shukra Pharmaceuticals Ltd. listed?

Shukra Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is 524632-BOM and the BSE code is -.

Where can I find the shareholding pattern of Shukra Pharmaceuticals Ltd.?

The quarterly shareholding pattern of Shukra Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Shukra Pharmaceuticals Ltd. on Sharpely?

Share price data for Shukra Pharmaceuticals Ltd. is updated as of 24 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.